Patients ( N = 784 ) received placebo , alogliptin ( A , 12.5 mg BID or 25mg QD ) , metformin ( M , 500 or 1000mg BID ) or A+M ( 12.5 / 500 or 12.5 / 1000mg BID ) ; placebo , A25 for secondary analyses only .